Opportunities Preloader

Please Wait.....

Report

Global Human Growth Hormone Market Report and Forecast 2023-2031

Market Report I 2023-07-05 I 140 Pages I EMR Inc.

Global Human Growth Hormone Market Report and Forecast 2023-2031

Global Human Growth Hormone Market Outlook

The global human growth hormone market attained a value of USD 5.2 billion in 2022, driven by increasing prevalence of growth hormone deficiency, growing demand for anti-aging treatments, and advancements in HGH formulations and delivery systems. The market is expected to grow at a CAGR of 8.49% during the forecast period of 2023-2031 to attain a value of USD 10.8 billion by 2031.

Human Growth Hormone: Introduction
Human growth hormone (HGH), also known as somatotropin, is a hormone produced naturally by the pituitary gland in the brain. It plays a vital role in stimulating growth and cell reproduction in humans. HGH is involved in various physiological processes and offers several uses and benefits.
The benefits of human growth hormone include:
- Growth and Development: HGH promotes normal growth and development in children and adolescents, ensuring proper bone growth, organ development, and overall physical maturation.
- Enhanced Muscle Function: HGH helps increase muscle mass, improve muscle strength, and enhance exercise performance. It is commonly used by athletes and bodybuilders to support muscle growth and improve athletic performance.
- Anti-Aging Effects: HGH has been associated with anti-aging effects, including improved skin elasticity, reduced wrinkles, and increased collagen production. It is believed to contribute to a more youthful appearance.
- Enhanced Healing and Recovery: Human growth hormone aids in tissue repair, wound healing, and recovery from injuries. It can help accelerate healing in certain conditions and improve recovery after surgeries or traumatic events.
- Metabolic Benefits: HGH plays a role in regulating metabolism, promoting fat breakdown, and supporting the development of lean muscle mass. It can help improve body composition, increase energy levels, and enhance metabolic functions.
It is important to note that the use of human growth hormone should be under medical supervision. HGH therapy is prescribed in specific medical conditions, such as growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, and certain chronic conditions. Self-administration or misuse of HGH without proper medical guidance can have adverse effects on health.
Human Growth Hormone Market Segmentations
The market can be categorised into application, distribution channel, and region.
Market Breakup by Application
- Growth Hormone Deficiency
- Turner Syndrome
- Idiopathic Short Stature
- Prader-Willi Syndrome
- Other Applications
Market Breakup by Distribution Channel
- Hospitals and Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Human Growth Hormone Market Overview
The human growth hormone (HGH) market has witnessed substantial growth and is expected to continue expanding in the coming years. Several factors contribute to the positive market scenario.
One of the primary drivers of market growth is the increasing prevalence of growth hormone deficiency and related disorders. Growth hormone deficiency can occur in children and adults, leading to growth retardation, short stature, and other health complications. The growing awareness and early diagnosis of these conditions have increased the demand for HGH therapy, driving market growth.
Moreover, the rising interest in anti-aging treatments and the pursuit of a youthful appearance have contributed to the market expansion. HGH is often associated with anti-aging effects, such as improved skin elasticity, reduced wrinkles, and increased muscle tone. The desire for youthful aesthetics and the demand for cosmetic enhancements have fuelled the market demand for HGH.
Furthermore, advancements in technology and pharmaceutical formulations have enhanced the availability and administration of HGH products. The development of long-acting formulations and innovative delivery systems has improved patient convenience and compliance. These advancements have made HGH therapy more accessible and user-friendly, positively impacting the market growth.
Additionally, the growing prevalence of chronic conditions such as Turner syndrome, Prader-Willi syndrome, and growth hormone deficiency associated with renal insufficiency has expanded the market for HGH. These conditions require long-term HGH therapy to manage symptoms, improve growth, and enhance quality of life.
Key Players in the Global Human Growth Hormone Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the human growth hormone market are as follows:

- AnkeBio Co. Ltd
- Eli Lilly and Company
- Ferring BV
- Novo Nordisk AS
- Ipsen SA
- Pfizer Inc.
- Genentech Inc. (Roche)
- Teva Pharmaceutical Industries Ltd.
- Ferring BV
- Anhui Anke Biotechnology (Group) Co.

*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Human Growth Hormone Market Overview
3.1 Global Human Growth Hormone Market Historical Value (2016-2022)
3.2 Global Human Growth Hormone Market Forecast Value (2023-2031)
4 Global Human Growth Hormone Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter's Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Human Growth Hormone Market Segmentation
5.1 Global Human Growth Hormone Market by Application
5.1.1 Market Overview
5.1.2 Growth Hormone Deficiency
5.1.3 Turner Syndrome
5.1.4 Idiopathic Short Stature
5.1.5 Prader-Willi Syndrome
5.1.6 Other Applications
5.2 Global Human Growth Hormone Market by Distribution Channel
5.2.1 Market Overview
5.2.2 Hospitals and Retail Pharmacies
5.2.3 Online Pharmacies
5.2.4 Other Distribution Channels
5.3 Global Human Growth Hormone Market by Region
5.3.1 Market Overview
5.3.2 North America
5.3.3 Europe
5.3.4 Asia Pacific
5.3.5 Latin America
5.3.6 Middle East and Africa
6 North America Growth Hormone Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Human Growth Hormone Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Human Growth Hormone Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.5 ASEAN
8.6 Australia
8.7 Others
9 Latin America Human Growth Hormone Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Human Growth Hormone Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Regulatory Framework
11.1 Regulatory Overview
11.1.1 US FDA
11.1.2 EU EMA
11.1.3 INDIA CDSCO
11.1.4 JAPAN PMDA
11.1.5 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 AnkeBio Co. Ltd
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Eli Lilly and Company
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Ferring BV
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Novo Nordisk AS
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Ipsen SA
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Pfizer Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Genentech Inc. (Roche)
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Teva Pharmaceutical Industries Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Ferring BV
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Anhui Anke Biotechnology (Group) Co.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications

18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE